Wells Fargo Maintains Overweight on Adient, Lowers Price Target to $28
Benzinga Newsdesk 7 months ago
NewsPrice TargetAnalyst Ratings
Wells Fargo analyst Colin Langan maintains Adient (NYSE:ADNT) with a Overweight and lowers the price target from $29 to $28.
Wells Fargo analyst Colin Langan maintains Adient (NYSE:ADNT) with a Overweight and lowers the price target from $29 to $28.